Senate bill extends breast cancer stamp sales to 2037
In committeeS. 4318Latest action
Sponsor: Jacky Rosen · Senator · NV
AIDecoded by AI · checked against the recordRead the official text
Official title: Breast Cancer Stamp Reauthorization Act
119th Congress
Topics: Government & democracy
Introduced:
Read the official bill on Congress.govIn plain words
The plain-language version comes first. The official text is always the reference.
This bill extends the breast cancer research postage stamp program from 2027 to 2037, keeping it available for ten more years.
45-second read · 5 questions answered below
What does this do?
This bill extends the expiration date for a special postage stamp that raises money for breast cancer research. The stamp costs slightly more than a regular stamp, and that extra amount goes to breast cancer research. Without this bill, the Postal Service's authority to sell the stamp would end in 2027; this bill moves that deadline to 2037.
Who does it affect?
Anyone who buys postage stamps could be affected, since they would continue to have the option to buy this stamp.
Why does it matter?
If the bill passes, the stamp remains available for purchase for an additional ten years. If it does not pass, the Postal Service loses the authority to sell the stamp after 2027.
What does it cost, and who pays?
- Costs slightly above standard postage
- Extra funds breast cancer research
AI-drafted summary. Check it against the official text before you act on it.
Read the official bill on Congress.govMake the call
Where does it stand?
- IntroducedApr 16, 2026
- Senate committeeYou are here · Apr 16, 2026
- Senate vote
- House
- The president's desk
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the president.
Latest action: — Read twice and referred to the Committee on Homeland Security and Governmental Affairs.